Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

Montalescot, Gilles; Barragan, Paul; Wittenberg, Olivier; Ecollan, Patrick; Elhadad, Simon; Villain, P; Boulenc, Jean-Marc; Morice, Marie‐Claude; Maillard, Luc; Pansiéri, Michel; Choussat, Rémi; Pinton, Philippe

doi:10.1056/nejm200106213442503

Public

Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

Published in New England Journal of Medicine • Jun 21, 2001

Authors:

Gilles Montalescot

Paul Barragan

Olivier Wittenberg

Abstract

BACKGROUND: When administered in conjunction with primary coronary stenting for the treatment of acute myocardial infarction, a platelet glycoprotein IIb/IIIa inhibitor may provide additional clinical benefit, but data on this combination therapy are limited. METHODS: We randomly assigned 300 patien...

Subject

Medicine

Abciximab

Myocardial infarction

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!